SPECT for preclinical imaging
Generate clear, quantifiable insight from molecular signals, so you can study biological processes with confidence and make stronger research decisions.
Ultra-high-resolution SPECT
Resolve small structures and faint signals, measure tracer behavior accurately, and strengthen study reproducibility. With MILabs’ U-SPECT system, you benefit from:
- ESub-0.25 mm in vivo total body mouse SPECT resolution (with uniformity)
- E0.12 mm ex vivo SPECT resolution for tumor or organ imaging
- EHighest sensitivity in the market
- EStationary detector design
- EHigh throughput speed
- EUltra-fast dynamic imaging with focused scans in as little as 1 second
- EHigh energy flexibility
Integrate SPECT with other imaging modalities
Build the configuration your research needs today, then expand it as your questions evolve.
VECTor: simultaneous molecular imaging without compromise
By combining ultra-high resolution SPECT, PET, and optional CT in a single platform, VECTor future-proofs your research while maintaining the performance, quantification, and workflow efficiency required for high-impact science. With VECTor, you benefit from:
- EBroadband molecular imaging across the full energy range (up to 1 MeV)
- ESupport for established, emerging, and experimental isotopes
- EQuantitative imaging without sacrificing resolution or sensitivity
- EA future-ready platform for evolving tracer strategies
- EMuli-isotope imaging like SPECT-PET, or PET-PET
- EPositron-free imaging of different PET isotopes
See imaging in action
See how researchers use MILabs SPECT systems to capture detail and quantify tracer behavior in translational and advanced research applications.
By combining SPECT with integrated optical imaging and high-performance anatomical CT, researchers can generate richer insight and operate at the forefront of translational research.
Hear from the experts
Imaging heterogeneous oncolytic virus spread in tumors at Mayo Clinic
FAQ
What is SPECT imaging?
SPECT (single photon emission computed tomography) is a molecular imaging technique that provides 3D functional images by detecting gamma rays emitted from radiolabeled tracers.
What is the difference between SPECT and PET imaging?
The main difference is the type of radiotracers used: SPECT detects gamma rays emitted directly from radiotracers, while PET detects gamma rays produced indirectly through positron interactions. Clinically, SPECT is typically more widely available and cost-effective, while PET is often associated with higher sensitivity. In preclinical research, SPECT systems can achieve exceptionally high resolution and support multi-isotope imaging in a single acquisition.
What are the benefits of U-SPECT from MILabs?
Researchers benefit from ultra-high resolution imaging for detailed quantitative datasets, combined with exceptional sensitivity and fast acquisition to support throughput. The system also offers flexibility across energy ranges, supporting a wide variety of tracers and applications.
What applications can U-SPECT be used for?
U-SPECT helps researchers visualize and quantify biological processes in vivo, supporting research areas including drug development, tracer development, biological models, neuroscience, cardiovascular research, and many more. MILabs also has an ultra-high resolution ex vivo option to scan tumors or organs as alternative for autoradiography. Find out how the system has been used.
Can U-SPECT be combined with any other imaging modalities?
Yes. U-SPECT can be combined with 2D or 3D optical imaging or anatomical CT systems from MILabs to expand imaging workflows and match evolving research needs. It can also be configured within broader integrated molecular imaging solutions, up to 1MeV including the imaging of 511 keV photons.